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Abstract
Background: Selection of patients for open abdomen (OA) treatment in severe acute pancreatitis (SAP) is
challenging. Treatment related morbidity and risk of adverse events are high; however, refractory abdominal
compartment syndrome (ACS) is potentially lethal. Factors influencing the decision to initiate OA treatment are
clinically important. We aimed to study these factors to help understand what influences the selection of patients
for OA treatment in SAP.
Methods: A single center study of patients with SAP that underwent OA treatment compared with conservatively
treated matched controls.
Results: Within study period, 47 patients treated with OA were matched in a 1:1 fashion with conservatively treated
control patients. Urinary output under 20 ml/h (OR 5.0 95% CI 1.8-13.7) and ACS (OR 4.6 95% CI 1.4-15.2)
independently associated with OA treatment. Patients with OA treatment had significantly more often visceral
ischemia (34%) than controls (6%), P = 0.002. Mortality among patients with visceral ischemia was 63%. Clinically
meaningful parameters predicting developing ischemia were not found. OA treatment associated with higher
overall 90-day mortality rate (43% vs 17%, P = 0.012) and increased need for necrosectomy (55% vs 21%, P = 0.001).
Delayed primary fascial closure was achieved in 33 (97%) patients that survived past OA treatment.
Conclusion: Decreased urine output and ACS were independently associated with the choice of OA treatment in
patients with SAP. Underlying visceral ischemia was strikingly common in patients undergoing OA treatment, but
predicting ischemia in these patients seems difficult.
Keywords: Abdominal compartment syndrome, Abdominal vac, Acute pancreatitis, Circulatory failure, Intra-
abdominal hypertension, ICU, Laparostomy, Multiple organ failure, Necrotizing pancreatitis, Negative-pressure
wound therapy, NPWT, Open abdomen, Organ failure, Renal failure, Severe acute pancreatitis, VAWCM, Vacuum-
assisted wound closure, Mesh-mediated fascial traction
Background
Intra-abdominal hypertension (IAH) affects most pa-
tients with severe acute pancreatitis (SAP). In acute pan-
creatitis, IAH correlates with significant mortality, and
escalation to abdominal compartment syndrome (ACS)
leads to dire outcomes [1, 2]. Disproportionate fluid re-
suscitation might aggravate IAH in SAP, leading ultim-
ately to ACS and increased risk of bowel ischemia [3].
Conservative management is the corner stone treatment
of elevated intra-abdominal pressure (IAP) [4]. When
ACS is refractory and resistant to conservative manage-
ment, surgical decompression via laparostomy with fol-
lowing open abdomen (OA) treatment is considered [4].
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Laparostomy efficiently diminishes IAP in SAP, but
whether or not it attenuates evolving ischemia or re-
verses existing organ failures in ACS is unknown [3].
Treatment with OA involves significant morbidity and
carries risk of undesired consequences, such as frozen
abdomen and enteroatmospheric fistulas [4–6]. Delayed
primary fascial closure can mostly be achieved when
utilizing dynamic fascial traction systems combined with
negative pressure wound therapy (typically vacuum-
assisted wound closure and mesh-mediated fascial trac-
tion, VAWCM) [7, 8]. Despite risk of serious conse-
quences, OA treatment is potentially life-saving when
patient endures worsening organ dysfunction due to
treatment-resistant ACS [9, 10].
As organ failure is characteristical and ACS occurs
commonly in SAP, patient selection and correct timing
of OA treatment remains clinically challenging. Enlight-
ening what influences the decision to engage OA treat-
ment might help narrow down selection of patients for
this morbid treatment. The main aim of this study was
to identify risk factors associated with the choice of OA
treatment in patients with SAP by comparing patients
with SAP that underwent OA treatment with matched
control patients with SAP that were managed conserva-
tively. Secondarily, we report and compare the outcomes
of these patients.
Methods
This was a matched case-control study of patients with
SAP comparing those that underwent OA treatment
with conservatively treated matched controls.
Data collection
We searched Helsinki University Hospital patient data-
base to obtain all patients with acute pancreatitis treated
between September 1, 2009 and December 31, 2019, at
Meilahti Hospital intensive care unit (ICU). Investigator
(H.H.) screened electronic medical records for possible
OA treatment of all patients with discharge ICD-10
diagnosis code K85.X or K86.X from ICU within men-
tioned timeframe. Study included only patients with SAP
according to the Revised Atlanta Classification [11]. Ex-
clusion from study occurred if admission to ICU was
later than 10 days or OA treatment later than 4 weeks
after hospital admission. In addition, initial treatment
abroad or pancreas transplant pancreatitis excluded pa-
tient from study. We collected a pre-specified list of var-
iables and summoned the information into a separate
patient database, replacing patient identification infor-
mation with running numbering. We collected the worst
and the best values of physiological parameters, such as
IAP, at 12-h intervals, and for laboratory test results at
daily intervals. These variables were collected preceding
OA treatment initiation for OA group patients and for
the corresponding time for matched control group
patients.
Conduction of study adhered to STROBE-guidelines
(https://strobe-statement.org/). Department of Abdom-
inal Surgery at Helsinki University Hospital approved
conduction of study. Institutional ethical committee as-
sessment was not required.
Definitions
Intra-abdominal hypertension was defined according to
consensus guidelines [4]. Repeatedly elevated IAP of
more than 20 mmHg accompanied by a new or worsen-
ing of an existing organ failure defined as ACS [4]. In at-
tempt to quantify exposure to possible intra-abdominal
ischemia due to ACS, we summated the gross time of
IAP higher than 20 mmHg accompanied by new or
worsened existing organ failure. Ischemia was defined as
irreversible necrosis of a viscera.
Procedure
All patients in the OA group underwent midline laparot-
omy. We utilized vacuum-assisted wound closure and
mesh-mediated fascial traction (VAWCM) for mainten-
ance and delayed primary fascia closure attempt of OA
[12]. Change of VAWCM with gradual approximation of
fascial edges occurred with a 2-4 days interval in the op-
erating theater. Selected patients had initially temporary
static laparostomy closure (i.e., skin bridging Bogota
bag), planning to continue with VAWCM treatment in
subsequent reoperations. Examples of such patients were
patients needing early second look (within 24 h) and pa-
tients needing continuous visual monitoring of intra-
abdominal status due to imminent risk of ischemia or
bleeding. We attempted delayed primary fascial closure
in all cases when possible after ACS subsided and only
used when needed anterior component separation tech-
nique via small separate horizontal transverse skin inci-
sions. Skin grafting was used selectively for complexity
class 3-4 OA with intention to later reconstruct symp-
tomatic ventral hernia [4].
Matching
Patients that underwent OA treatment were matched
with controls in a 1:1 ratio. Control patients had SAP
but avoided OA treatment within entire hospital treat-
ment period. We calculated maximum daily Sequential
Organ Failure Assessment (SOFA) score for each patient
in OA group and possible matched control during the
first 3 days after ICU admission. The primary matching
criteria was highest SOFA score within 72 h from ICU
admission. When there was more than one eligible con-
trol patient, we used (in order of importance) age, pre-
ceding comorbidities, and year of treatment as
secondary matching criteria. Maximum deviance of
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SOFA score ± 2 and age ± 10 years were allowed be-
tween OA-treated patients and their matched controls.
Statistical analysis
We analyzed the acquired data in SPSS (IBM. Corp.,
Armonk, NY, USA). Level of statistical significance was
P < 0.05. Fisher’s exact two-sided test, Mann-Whitney U
test, and log-rank test were used as appropriate. Receiver
operating characteristics (ROC) analysis guided conver-
sion of continuous variables to dichotomous.
For the primary aim, we compared mean and most ab-
normal values of physiological parameters in OA and
control group patients by means of univariate analysis.
Clinically interesting variables with statistical signifi-
cance in univariate analysis that had a meaningful cut-
off value in ROC analysis were entered into backward lo-
gistic multivariable analysis. We calculated odds ratios
(OR) and 95% confidence intervals (CI) for the multivar-
iable logistic regression analysis.
For the secondary aim, we compared outcomes of OA
and matched control group patients by means of
univariate analysis. We performed a post hoc univariate




The systematic search of patient database resulted in 47
patients with OA treatment matched with 47 conserva-
tively treated controls. Flow chart (Fig. 1) illustrates pa-
tient obtainment in study. Additional file 1 provides
detailed information of patient matching. Due to other-
wise insufficient number of control patients, we allowed
a violation of the pre-specified matching principles in
the following three cases: one OA-treated patient with
SOFA score 19 was matched with a control patient with
SOFA score 16, and two patients were matched despite
11 years age difference.
Patients
Baseline characteristics of patients appear in Table 1.
Forty (85%) patients in OA group suffered from ACS
* Open abdomen > 28 days from hospitalization
Fig. 1 Flow chart
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compared to 21 (45%) control patients, P <0.001. In OA
group, 32 (68%) patients suffered from less than 20 ml/h
urine output compared to 14 (30%) patients in control
group, P < 0.001. Indication for OA treatment was re-
fractory ACS in 40 (85%) patients, and abdomen was left
open after explorative laparotomy in 7 (15%) patients.
OA treatment commenced at a median of 60 (IQR 36-
175) and 37 (IQR 17-125) hours from admission to hos-
pital and ICU, respectively.
Factors associated with OA treatment
Shown in Table 2 are results of univariate analysis of
physiological parameters in OA group patients and
matched controls. Rationale behind conversion of con-
tinuous to dichotomous variables is shown in Additional
file 2. Table 3 summons the results of multivariable ana-
lysis of factors associated with OA treatment. Less than
20 ml/h urine output (OR 5.0 95% CI 1.8-13.7) and ACS
(OR 4.6 95% CI 1.4-15.2) independently associated with
increased risk of OA treatment.
Comparison of outcomes
As can be seen in Table 4, OA group patients suffered
significantly more often than matched controls from vis-
ceral ischemia (16 [34%] vs 3 [6%] patients, P = 0.002),
needed more often necrosectomy (26 [55%] vs 10 [21%]
patients, P = 0.001), and overall mortality was higher (20
[42%] vs 8 [17%] patients, P = 0.010). In 90-day survi-
vors, overall median hospital (73 vs 30 days) and ICU
(37 vs 14 days) lengths of stays were longer in OA group
than control patients, P <0.001.
Visceral ischemia
In the OA group, median time of ACS duration before
initiating OA treatment was statistically similar in
patients with (median 7 h, IQR 1-38 h) and without (me-
dian 14 h, IQR 7-33h) visceral ischemia, P = 0.317.
Altogether 11 (23%) OA-treated patients suffered from
bowel ischemia, including colonic, small bowel, and both
colonic and small bowel ischemia in 6 (13%), 1 (2%), and
4 (9%) patients, respectively. Independently or in con-
junction with bowel ischemia, 7 (15%), 3 (6%), and 1
(2%) OA-treated patient suffered from gall bladder,
omental, and gastric ventricle ischemia, respectively.
Three (6%) patients from matched control group suf-
fered from colonic ischemia, and small bowel ischemia
appeared jointly in all but one. Two of these patients
had endured ACS and the third patient had acute renal
failure and needed continuous renal replacement ther-
apy. Overall mortality of 19 patients with visceral ische-
mia (including patients from both study groups) was
63%, including 6 deaths out of 7 patients with small
bowel ischemia. Post hoc analysis of risk factors for vis-
ceral ischemia in OA-treated patients only found lower
mean CRP value in patients enduring ischemia com-
pared to other patients (Additional file 3). Presented in
Additional file 4 are detailed description of all patients
with visceral ischemia.
Abdominal closure
Thirteen (28%) patients died with ongoing OA treat-
ment. Among 34 patient who survived to abdominal
closure, 33 (97%) had delayed primary fascial closure (in-
cluding 5 [15%] patients requiring separation of compo-
nents), and one (3%) patient needed split-thickness skin
grafting on granulated abdominal wound due to frozen
abdomen and enteroatmospheric fistula. Median time
interval between initiated OA treatment and abdominal
closure was 20 (IQR 12-28) days.
Table 1 Patient characteristics at admission to intensive care unit
Open abdomen (n = 47) Matched Controls (n = 47) P
Age, median (range), years 49 (27–82) 50 (18–78) 0.456
BMI, mean ± SD, kg/m2 30.4 ± 4.9 30.4 ± 4.9 0.991
Male sex 42 (89) 41 (87) 1.000
Alcoholic etiology * 40 (85) 34 (72) 0.207
Tertiary referral 18 (38) 16 (34) 0.830
ASA ≥ III 32 (68) 25 (53) 0.205
SOFA < 72 h † 13 (11–14) 12 (10–15) 0.876
APACHE II < 24 h † 23 (17–29) 18 (15–26) 0.056
Time interval between hospital and ICU admission, hours † 23 (8–33) 28 (12–40) 0.318
Presented values are absolute number of patients (number in brackets is percentage) unless stated otherwise
*Open abdomen: biliary (2), hypertriglyceridemia (2), other/idiopathic (2), postoperative (1). Matched controls: biliary (7), other/idiopathic (4), hypertriglyceridemia
(1), post-ERCP (1)
†Median (interquartile range)
APACHE II, Acute Physiology and Chronic Health Evaluation II Scoring System; ASA, American Society of Anesthesiologists Physical Status Classification System; BMI,
body mass index; CI, confidence interval; ERCP, endoscopic retrograde cholangiopancreatography; ICU, intensive care unit; OR, odds ratio; SD, standard deviation;
SOFA, Sequential Organ Failure Assessment score
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Discussion
We conducted a study comparing OA- and conserva-
tively treated SAP patients. Results show that decreased
urine output and ACS were independently associated with
the choice of OA treatment in SAP. Ischemia was remark-
ably common in OA-treated patients, but conventional
physiological parameters were inaccurate predictors of de-
veloping ischemia. As expected, OA treatment associated
with increased morbidity and mortality, most probably due
to a more severe disease than the decompressive surgery it-
self. Delayed primary fascial closure was almost always
achievable if patients endured and survived the OA treat-
ment period.
Present study found an independent association be-
tween decreased urine output and utilization of OA
treatment in SAP. In line with such clinical practice, a
recent meta-analysis of patients with ACS for various
reasons concluded that especially urine output alongside
respiratory parameters improve following OA treatment
[13]. In an experimental animal model of ACS in SAP,
reduction of urine output was reversible to baseline if
laparostomy was performed before urine output
Table 2 Univariate analysis of physiological parameters in open abdomen and matched control group
Open abdomen (n = 47) Matched controls (n = 47) P
MAP lowest (24 h) ± SD, mmHg * 63 ± 9 67 ± 10 0.092
MAP mean ± SD, mmHg † 79 ± 8 85 ± 11 0.004
IAP highest (24 h), ± SD, mmHg *‡ 24 ± 4 21 ± 5 < 0.001
IAP mean ± SD, mmHg †‡ 20 ± 3 17 ± 3 < 0.001
APP lowest (24 h), ± SD, mmHg *‡ 46 ± 9 56 ± 13 < 0.001
APP mean ± SD, mmHg †‡ 58 ± 9 68 ± 11 < 0.001
Urine output lowest (24 h) ± SD, ml/h * 19 ± 29 41 ± 36 < 0.001
Urine output mean ± SD, ml/h † 31 ± 31 72 ± 66 < 0.001
Plasma creatinine highest (24 h) ± SD, umol/L * 216 ± 163 213 ± 174 0.484
Plasma creatinine mean ± SD, umol/L † 209 ± 159 181 ±146 0.064
Plasma urea highest (24 h) ± SD, mmol/L *‡ 11.9 ± 9.0 13.2 ± 10.2 0.692
Plasma urea mean ± SD, mmol/L †‡ 11.3 ± 8.5 11.3 ± 7.8 0.753
PaO2/FiO2 lowest (24 h) ± SD * 142 ± 58 140 ± 66 0.631
PaO2/FiO2 mean ± SD † 199 ± 65 207 ± 76 0.973
Blood leucocyte count highest (24 h) ± SD, 109/L 18.7 ± 12.9 14.1 ± 7.8 0.119
Blood leucocyte count mean ± SD, 109/L 16.0 ± 9.1 11.9 ± 6.1 0.016
Platelet count lowest (24 h) ± SD, 109/L * 162 ± 122 120 ± 105 0.083
Platelet count mean ± SD, 109/L † 142 ± 83 142 ± 114 0.666
Plasma bilirubin highest (24 h) ± SD, umol/L * 45 ± 46 58 ± 51 0.041
Plasma bilirubin mean ± SD, umol/L † 43 ± 41 48 ± 38 0.261
Plasma CRP highest (24 h) ± SD, mg/L * 319 ± 129 319 ± 170 0.725
Plasma CRP mean ± SD, mg/L † 311 ± 128 273 ± 134 0.150
GCS lowest (24 h) (IQR) * 15 (13–15) 15 (14–15) 0.509
GCS mean (IQR) † 15 (14–15) 15 (14–15) 0.672
Plasma lactate highest (24 h) ± SD, mmol/L * 4.8 ± 4.2 3.5 ± 2.6 0.403
Plasma lactate mean ± SD, mmol/L † 4.5 ± 3.9 2.9 ± 2.6 0.014
Base-excess lowest (24 h) ± SD, mmol/L * −8.0 ± 6.6 −7.6 ± 4.2 0.871
Base-excess mean ± SD, mmol/L † −7.5 ± 6.4 −5.1 ± 4.6 0.085
Arterial pH, mean ± SD || 7.22 ± 0.14 7.29 ± 0.10 0.016
Serum potassium, mean ± SD, mmol/l || 5.3 ± 1.1 4.6 ± 0.9 0.001
Serum sodium, mean ± SD, mmol/l || 127 ± 5 130 ± 6 0.008
Cumulative excess fluid balance ± SD, ml 12267 ± 7374 8616 ± 6888 0.020
*Mean of most divergent value within 24 h from laparostomy (OA group) vs. mean of most divergent value within entire follow-up period (matched controls)
†Mean of all preceding values
‡One missing value in group open abdomen (n = 46)
||Mean of most divergent values within 24 h from ICU admission
APP, abdominal perfusion pressure; CI, confidence interval; CRP, C-reactive protein; GCS, Glasgow coma scale; IAP, intra-abdominal pressure; IQR, interquartile
range; MAP, mean arterial pressure; OR, odds ratio; SD, standard deviation
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decreased to around 20 ml/h [14]. Urine output declin-
ing to 20 ml/h (oliguria) independently predicted choice
of OA treatment in our study; however, this result can-
not be interpreted as a guideline for initiating OA treat-
ment as such. A significant number of control patients
were treated conservatively despite declining urine out-
put. There is need for further research to determine a
potentially optimal threshold for decompression in SAP
when ACS is persistent.
Since refractory and treatment resistant ACS is consid-
ered an indication for OA treatment, it is intuitive that
current study showed an independent association be-
tween existence of ACS and subsequent choice of OA
treatment. Interestingly, around half of control group
patients suffered from ACS, and endured ACS that
lasted for at least as long as in OA group patients. Al-
though not quantifiable with the current studied vari-
ables, it is likely that patients selected for OA treatment
simply were deteriorating faster with an illness more re-
sistant to maximal supportive treatment. We find that
the substantial proportion of patients with visceral ische-
mia symbolizes the distress that led to intervention.
Although presented in sophisticated animal models
[15, 16], to date, no study in humans has proven correl-
ation between elevation of IAH and development of vis-
ceral ischemia. The available data regarding ischemic
complications in SAP is sparse. Smit et al. reported
higher incidence (61.5%) of intra-abdominal ischemia in
a series of 13 SAP-patients with ACS [17]. In study by
Maatman and colleague’s, ischemia or perforation of the
colon was present in around 7%; however, this cohort
included the entire spectrum of patients with necrotizing
pancreatitis. In a recent systematic review of patients
with ACS of multiple etiologies, cause of death was re-
lated to intestinal ischemia in 15% of patients [13]. A
third of OA-treated patients in the present study suf-
fered from visceral ischemia despite decompressive ef-
fort. For these patients, decompression might have come
too late, as irreversible development of ischemia had
already occurred. Another possible explanation is that is-
chemia developed due to visceral hypoperfusion unre-
lated to intra-abdominal pressure, which has previously
been associated with a similarly poor outcome as in pa-
tients with visceral ischemia in our study [18]. Only a
third of our study patients with visceral ischemia sur-
vived, which is comparable to what has previously been
reported (55%) [17]. Based on the current experience,
small bowel ischemia within the context of SAP associ-
ates with a devastating outcome, as mortality reached
nearly 90%. We were, unfortunately, unable to find
meaningful clinical parameters that would have pre-
dicted evolving ischemia.
In the present study, around half of patients with OA
treatment for ACS died within 90 days. Risk of death is
around two-thirds when considering only patients with
Table 3 Multivariable analysis of factors associated with open
abdomen
OR (95% CI) P
Urine output ≤ 20 ml/h * 4.99 (1.82–13.69) 0.002
Abdominal compartment syndrome † 4.64 (1.42–15.20) 0.011
IAP ≥ 24 mmHg * 3.00 (0.98–9.20) 0.055
Backward conditional logistic regression based on data in Table 2. Variables
for the model were chosen based on clinical usefulness and statistical
significance. Receiver operator characteristics curve was plotted to convert
continuous variables to dichotomous. Other variables that were included in
model: APP < 50 mmHg*, cumulative excess fluid balance > 10,000 ml.
*Most divergent value within 24 h from laparostomy for OA group and within
entire follow-up period for matched controls
†IAP > 20 mmHg and new or worsening of existing organ failure
CI, confidence interval; IAP, intra-abdominal pressure; OR, odds ratio; SD,
standard deviation
Table 4 Univariate analysis of outcomes in open abdomen and matched control group
Open abdomen (n = 47) Matched controls (n = 47) P
Mortality within 90 days from ICU admission
All patients 20 (43) 8 (17) 0.010
Patients with visceral ischemia * 10 (63) 2 (67) 0.685
Patients without visceral ischemia * 10 (32) 6 (14) 0.066
Patients with abdominal compartment syndrome *† 19 (48) 3 (14) 0.013
Visceral ischemia 16 (34) 3 (6) 0.002
Necrosectomy within 90 days from ICU admission 26 (55) 10 (21) 0.001
Survivor without necrosectomy ‡ 9 (19) 30 (64) 0.004
Time interval between ICU admission and death, median (range), days 13 (0-73) 1 (0-88) 0.138
Number in brackets means percentage unless stated otherwise. Mortality/survival analysis implemented log-rank test. Remaining analysis utilized Fisher’s exact
2-sided test
*Presented is the percentage of patients with the risk factor in question
†Forty open abdomen patients and 21 matched controls suffered from abdominal compartment syndrome
‡Patients that did not undergo necrosectomy and survived 90 days following ICU admission
ICU, intensive care unit
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visceral ischemia. These outcomes are in line with previ-
ously reported mortality between 25 and 71% in patients
with laparostomy for ACS in SAP [9, 17, 19, 20]. As
shown by our results, the remainder of patients treated
with OA suffers from significant morbidity in terms of
repeat invasive procedures and length of stay. If patient
survives past the initial struggles and intra-abdominal
conditions become more favorable, delayed fascial clos-
ure of abdomen is achievable in almost all patients. This
result is comparable with previous experiences of
VAWCM treatment in patients with OA [21]. Despite
past decades increased knowledge in prevention and ef-
fects of elevated IAP in the critically ill, the outcomes of
our study patients are generally quite upsetting, espe-
cially as maximal invasive treatment efforts were
invested. This study cannot provide any estimate of what
effect OA treatment might have on outcomes as under-
lying physiological derangements are likely to be differ-
ent between groups. The reported associations on
outcomes should therefore not be interpreted as
causation.
Our results show that ACS is a common finding in pa-
tients with SAP, and that far from all patients requires
surgical decompression despite persistence to conserva-
tive management. Ischemia is a common finding follow-
ing laparostomy for ACS in SAP. Unfortunately, efforts
to salvage patient were mostly futile when ischemia had
occurred. Irreversible ischemic changes manifested in
these patients previous to laparostomy. Unfortunately,
no conclusions can be made whether earlier intervention
might have improved the outcome.
An obvious weakness of this study is the observa-
tional retrospective nature. Matching principles is a
known potential introducer of unsolicited selection
bias. Despite our efforts to find conservatively
treated matching peers by early phase maximal ini-
tial SOFA score, it seems that OA-treated patients
still were sicker at baseline. Difference in APACHE
II score at admission to ICU depicts this trend;
however, choice of a different risk stratification tool
than SOFA score would likely not have obviated
this selection bias. Due to the rarity of patients
even being considered for surgical decompression
of ACS in SAP, there are to date no randomized
trials comparing conservative and OA treatment,
which depicts the difficulty to study such events.
Limiting the applicability of our study results is
that indication for OA treatment was not standard-
ized and depended on shared decision-making by
the surgeon on call and anesthesiologist in charge
of patient at ICU. Another weakness is the absence
of standardized long-time follow-up that could have
shed light on associated long-time morbidity, func-
tional outcomes, and quality of life.
Conclusions
In patients with SAP, decreased urine output under 20
ml/h and fulfilling ACS criteria independently increase
the risk of OA treatment. OA-treated patients often suf-
fer from visceral ischemia; however, clinically meaningful
predictors of ischemia seem hard to identify.
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